WOWI, Inc (WOWU) Fair Value & Analysis
Healthcare · US · Market cap $6.8K
WOWI, Inc
WOWU · US
Fair value as of: Jun 26, 2026
From 12 valuation models · updated 7 days ago
Price vs Fair Value (12 months)
12‑month range $0.0002 – $0.0002 · the $0.0002 price screens below the $0.0002 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
WOWI, Inc (WOWU) currently trades at $0.0002, while our model-based Fair Value estimate is $0.0002 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 51/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
WOWI, Inc., an early-stage company, engages in the business of licensing technology and intellectual property to operators and businesses in the legal cannabis industry in the United States. The company also provides packaging and labeling, as well as equipment and real property leasing services to various companies. In addition, it offers a plethora of consulting services, including proper business structure and management services in the legal cannabis space serving cultivations, growers, extractors, and dispensaries that operate legally in states that has legal medicinal and/or recreational legislation. The company is headquartered in Centennial, Colorado.
Revenue & earnings trend
FY2011 – FY2023 · reported fiscal years
WOWI, Inc reported revenue of $390K in FY2023 versus $20.0K in FY2011, a compound +28.1%/yr. Reported net income was $91.8K in FY2023.
Is WOWU fairly valued? → Check now
Similar stocks
6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 1276 | HK$57.85 | HK$29.84 | -48% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,782 | ₹915.92 | -49% |
| Zoetis Inc Z1TS34 | R$24.45 | R$6.33 | -74% |
| Hansoh Pharmaceutical Group 3692 | HK$29.32 | HK$23.94 | -18% |
| Divi's Laboratories Limited DIVISLAB | ₹6,623 | ₹1,461 | -78% |
| Swedish Orphan Biovitrum AB SOBI | kr 446.60 | kr 234.19 | -48% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is WOWI, Inc (WOWU) undervalued?
What is the fair value of WOWU?
What is the quality score of WOWU?
What is the net profit margin of WOWU?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.